Post Date:Feb-08-22
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
Author: AcceGen R&D TeamDate Published: 08-Feb-22
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
- Authors: Wei-Ching Chen, Minh D. To, Peter M. K. Westcott, Reyno Delrosario, Il-Jin Kim, Mark Philips, Quan Tran, Saumya R. Bollam, Hani Goodarzi, Nora Bayani, Olga Mirzoeva & Allan Balmain
- Journal: Nature Communications
- DOI: 10.1038/s41467-021-24498-7
- Cited AcceGen Product/Service: SUIT-2
Copyright - Unless otherwise stated all contents of this website are AcceGen™ All Rights Reserved – Full details of the use of materials on this site please refer to AcceGen Editorial Policy – Guest Posts are welcome, by submitting a guest post to AcceGen you are agree to the AcceGen Guest Post Agreement – Any concerns please contact marketing@accegen.com
